Annual Current Liabilities
$4.54 M
-$2.50 M-35.55%
01 December 2023
Summary:
COSCIENS Biopharma annual total current liabilities is currently $4.54 million, with the most recent change of -$2.50 million (-35.55%) on 01 December 2023. During the last 3 years, it has fallen by -$202.00 thousand (-4.26%).CSCI Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$8.17 M
-$1.73 M-17.49%
01 September 2024
Summary:
COSCIENS Biopharma quarterly total current liabilities is currently $8.17 million, with the most recent change of -$1.73 million (-17.49%) on 01 September 2024. Over the past year, it has increased by +$6.96 million (+577.98%).CSCI Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CSCI Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -35.5% | +578.0% |
| 3 y3 years | -4.3% | +611.0% |
| 5 y5 years | -18.9% | +481.0% |
CSCI Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | -94.6% | -17.5% |
COSCIENS Biopharma Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $8.17 M(-17.5%) |
| June 2024 | - | $9.90 M(+698.4%) |
| Mar 2024 | - | $1.24 M(-5.4%) |
| Dec 2023 | $4.54 M(-35.5%) | $1.31 M(+8.8%) |
| Sept 2023 | - | $1.20 M(+96.9%) |
| June 2023 | - | $611.70 K(-43.5%) |
| Mar 2023 | - | $1.08 M(-30.0%) |
| Dec 2022 | $7.04 M(-9.3%) | $1.55 M(+151.4%) |
| Sept 2022 | - | $615.70 K(-13.5%) |
| June 2022 | - | $711.70 K(+4.5%) |
| Mar 2022 | - | $681.00 K(-10.7%) |
| Dec 2021 | $7.77 M(+63.8%) | $762.40 K(-33.6%) |
| Sept 2021 | - | $1.15 M(+16.8%) |
| June 2021 | - | $983.00 K(+10.2%) |
| Mar 2021 | - | $892.30 K(-18.2%) |
| Dec 2020 | $4.74 M(-16.2%) | $1.09 M(+11.7%) |
| Sept 2020 | - | $975.90 K(+10.3%) |
| June 2020 | - | $884.80 K(+1.5%) |
| Mar 2020 | - | $871.50 K(-34.6%) |
| Dec 2019 | $5.66 M(+1.1%) | $1.33 M(-5.2%) |
| Sept 2019 | - | $1.41 M(+15.6%) |
| June 2019 | - | $1.22 M(-1.5%) |
| Mar 2019 | - | $1.23 M(+23.6%) |
| Dec 2018 | $5.60 M(-3.0%) | $998.30 K(-39.6%) |
| Sept 2018 | - | $1.65 M(-48.1%) |
| June 2018 | - | $3.19 M(+6.2%) |
| Mar 2018 | - | $3.00 M(-7.2%) |
| Dec 2017 | $5.77 M(+37.2%) | $3.23 M(+124.2%) |
| Sept 2017 | - | $1.44 M(-12.7%) |
| June 2017 | - | $1.65 M(-6.9%) |
| Mar 2017 | - | $1.77 M(-5.9%) |
| Dec 2016 | $4.20 M(-34.6%) | $1.89 M(-26.3%) |
| Sept 2016 | - | $2.56 M(-25.8%) |
| June 2016 | - | $3.45 M(-10.5%) |
| Mar 2016 | - | $3.85 M(+2.8%) |
| Dec 2015 | $6.42 M(-15.2%) | $3.75 M(+65.5%) |
| Sept 2015 | - | $2.26 M(+0.0%) |
| June 2015 | - | $2.26 M(+12.8%) |
| Mar 2015 | - | $2.01 M(-21.4%) |
| Dec 2014 | $7.57 M(+4.6%) | $2.55 M(+23.0%) |
| Sept 2014 | - | $2.08 M(-20.6%) |
| June 2014 | - | $2.62 M(+22.7%) |
| Mar 2014 | - | $2.13 M(+2.6%) |
| Dec 2013 | $7.24 M(-53.9%) | $2.08 M(+18.0%) |
| Sept 2013 | - | $1.76 M(-5.5%) |
| June 2013 | - | $1.86 M(+1.2%) |
| Mar 2013 | - | $1.84 M(-28.6%) |
| Dec 2012 | $15.71 M(-12.2%) | $2.58 M(-3.2%) |
| Sept 2012 | - | $2.67 M(+26.6%) |
| June 2012 | - | $2.11 M(-16.1%) |
| Mar 2012 | - | $2.51 M(+69.6%) |
| Dec 2011 | $17.89 M(+32.6%) | $1.48 M(-7.5%) |
| Sept 2011 | - | $1.60 M(-5.8%) |
| June 2011 | - | $1.70 M(-5.0%) |
| Mar 2011 | - | $1.79 M(-7.5%) |
| Dec 2010 | $13.49 M | $1.93 M(+21.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2010 | - | $1.59 M(-10.7%) |
| June 2010 | - | $1.78 M(-19.1%) |
| Mar 2010 | - | $2.20 M(+8.6%) |
| Dec 2009 | $19.27 M(-13.1%) | $2.02 M(-12.8%) |
| Sept 2009 | - | $2.32 M(+7.2%) |
| June 2009 | - | $2.16 M(-17.9%) |
| Mar 2009 | - | $2.64 M(-6.9%) |
| Dec 2008 | $22.17 M(-0.4%) | $2.83 M(+42.3%) |
| Sept 2008 | - | $1.99 M(+17.7%) |
| June 2008 | - | $1.69 M(+64.1%) |
| Mar 2008 | - | $1.03 M(+19.8%) |
| Dec 2007 | $22.25 M(+36.5%) | $860.60 K(+3.6%) |
| Sept 2007 | - | $830.50 K(-28.8%) |
| June 2007 | - | $1.17 M(+37.7%) |
| Mar 2007 | - | $847.60 K(+53.4%) |
| Dec 2006 | $16.31 M(-74.6%) | $552.50 K(+31.1%) |
| Sept 2006 | - | $421.40 K(-49.2%) |
| June 2006 | - | $829.60 K(+8.0%) |
| Mar 2006 | - | $768.20 K(+21.2%) |
| Dec 2005 | $64.17 M(+6.7%) | $633.80 K(+4.2%) |
| Sept 2005 | - | $608.40 K(-25.7%) |
| June 2005 | - | $818.70 K(-13.5%) |
| Mar 2005 | - | $946.40 K(+6.8%) |
| Dec 2004 | $60.12 M(+26.9%) | $886.50 K(+32.5%) |
| Sept 2004 | - | $668.90 K(-2.7%) |
| June 2004 | - | $687.60 K(+77.7%) |
| Mar 2004 | - | $387.00 K(-32.6%) |
| Dec 2003 | $47.38 M(-43.6%) | $574.30 K(+41.1%) |
| Sept 2003 | - | $407.00 K(-7.1%) |
| June 2003 | - | $438.30 K(-15.2%) |
| Mar 2003 | - | $516.70 K(+30.7%) |
| Dec 2002 | $83.99 M(+397.5%) | $395.30 K(-14.3%) |
| Sept 2002 | - | $461.30 K(-22.9%) |
| June 2002 | - | $598.60 K(+17.3%) |
| Mar 2002 | - | $510.40 K(+30.2%) |
| Dec 2001 | $16.88 M(+270.9%) | $392.00 K(-8.5%) |
| Sept 2001 | - | $428.60 K(-31.6%) |
| June 2001 | - | $626.20 K(-46.2%) |
| Mar 2001 | - | $1.16 M(-21.1%) |
| Dec 2000 | $4.55 M(+161.0%) | $1.47 M(-19.5%) |
| Sept 2000 | - | $1.83 M(+0.5%) |
| June 2000 | - | $1.82 M(+39.4%) |
| Mar 2000 | - | $1.31 M(-9.8%) |
| Dec 1999 | $1.74 M(-23.3%) | $1.45 M(+18.3%) |
| Sept 1999 | - | $1.23 M(+6.3%) |
| June 1999 | - | $1.15 M(+2.4%) |
| Mar 1999 | - | $1.13 M(+15.6%) |
| Dec 1998 | $2.27 M(+103.4%) | $974.80 K(-12.5%) |
| Sept 1998 | - | $1.11 M(-47.2%) |
| June 1998 | - | $2.11 M(+7.0%) |
| Mar 1998 | - | $1.97 M(-17.0%) |
| Dec 1997 | $1.12 M(+39.3%) | $2.38 M(-54.4%) |
| Sept 1997 | - | $5.21 M(+35.8%) |
| June 1997 | - | $3.84 M(+12.7%) |
| Mar 1997 | - | $3.41 M |
| Dec 1996 | $802.70 K | - |
FAQ
- What is COSCIENS Biopharma annual total current liabilities?
- What is the all time high annual current liabilities for COSCIENS Biopharma?
- What is COSCIENS Biopharma annual current liabilities year-on-year change?
- What is COSCIENS Biopharma quarterly total current liabilities?
- What is the all time high quarterly current liabilities for COSCIENS Biopharma?
- What is COSCIENS Biopharma quarterly current liabilities year-on-year change?
What is COSCIENS Biopharma annual total current liabilities?
The current annual current liabilities of CSCI is $4.54 M
What is the all time high annual current liabilities for COSCIENS Biopharma?
COSCIENS Biopharma all-time high annual total current liabilities is $83.99 M
What is COSCIENS Biopharma annual current liabilities year-on-year change?
Over the past year, CSCI annual total current liabilities has changed by -$2.50 M (-35.55%)
What is COSCIENS Biopharma quarterly total current liabilities?
The current quarterly current liabilities of CSCI is $8.17 M
What is the all time high quarterly current liabilities for COSCIENS Biopharma?
COSCIENS Biopharma all-time high quarterly total current liabilities is $9.90 M
What is COSCIENS Biopharma quarterly current liabilities year-on-year change?
Over the past year, CSCI quarterly total current liabilities has changed by +$6.96 M (+577.98%)